CAPTRUST FINANCIAL ADVISORS - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 218 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2022$3,000
-66.7%
108
-58.6%
0.00%
Q1 2022$9,000
-71.9%
261
-76.4%
0.00%
Q4 2021$32,000
+28.0%
1,106
+15.0%
0.00%
Q3 2021$25,000
-16.7%
962
+11.1%
0.00%
Q2 2021$30,000
-16.7%
866
-2.0%
0.00%
Q1 2021$36,000
+227.3%
884
+233.6%
0.00%
Q4 2020$11,000
-21.4%
265
+6.0%
0.00%
Q3 2020$14,000
-22.2%
2500.0%0.00%
Q2 2020$18,000
-53.8%
250
-68.9%
0.00%
-100.0%
Q3 2019$39,000
-7.1%
805
+0.8%
0.00%
-50.0%
Q2 2019$42,0007990.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2021
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 383,702$14,581,0007.71%
Perceptive Advisors 5,148,910$195,658,0005.23%
Grace Capital 312,514$11,876,0004.65%
NEXTHERA CAPITAL LP 549,231$20,871,0004.00%
Asymmetry Capital Management, L.P. 103,449$3,931,0003.63%
Camber Capital Management LP 2,075,000$78,850,0003.37%
Casdin Capital, LLC 440,000$16,720,0002.03%
EMORY UNIVERSITY 53,951$2,050,0001.34%
ArchPoint Investors 129,435$4,919,0001.34%
Ghost Tree Capital, LLC 150,000$5,700,0001.21%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders